FDAがRECOVER IVのEFIC(インフォームド・コンセント例外)付き,Improving stroke risk prediction by integrating XGBoost,Atezolizumab as first-line treatment in cisplatin-ineligible,Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES | Circulation,Restore EF試験で、Impella補助による高リスクPCI患者の心機能